DrugPatentWatch Database Preview
Drugs in Development Information for Sulodexide
Development status for investigational drug Sulodexide: Patents, clinical trial progress, indications
Sulodexide is an investigational drug.
There have been 13 clinical trials for Sulodexide.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2015.
The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Albuminuria. The leading clinical trial sponsors are Keryx Biopharmaceuticals, Collaborative Study Group (CSG), and Corbridge Group Philippines, Inc.
There are seventy US patents protecting this investigational drug and four hundred and nine international patents.
Summary for Sulodexide
| US Patents | 70 |
| International Patents | 409 |
| US Patent Applications | 232 |
| WIPO Patent Applications | 20 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2015-09-01) |
| Vendors | 6 |
Recent Clinical Trials for Sulodexide
| Title | Sponsor | Phase |
|---|---|---|
| Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) | University Medical Center Groningen | Phase 4 |
| Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) | Steno Diabetes Center | Phase 4 |
| Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide | Bama GeVe, S.L.U. | Phase 4 |
Clinical Trial Summary for Sulodexide
Top disease conditions for Sulodexide
Top clinical trial sponsors for Sulodexide
US Patents for Sulodexide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sulodexide | Start Trial | Nucleic acid vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Polynucleotides encoding immune modulating polypeptides | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Human cytomegalovirus RNA vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Efficient protein expression in vivo using modified RNA (MOD-RNA) | THE GENERAL HOSPITAL CORPORATION (Boston, MA) CHILDREN'S MEDICAL CENTER CORPORATION (Boston, MA) | Start Trial |
| Sulodexide | Start Trial | Zika virus RNA vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Manufacturing methods for production of RNA transcripts | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sulodexide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sulodexide | Australia | 2015249553 | 2034-04-23 | Start Trial |
| Sulodexide | Brazil | 112016024644 | 2034-04-23 | Start Trial |
| Sulodexide | Canada | 2946751 | 2034-04-23 | Start Trial |
| Sulodexide | China | 106659803 | 2034-04-23 | Start Trial |
| Sulodexide | European Patent Office | 3134131 | 2034-04-23 | Start Trial |
| Sulodexide | Japan | 2017513956 | 2034-04-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
